Clinical Trials Browser

Phase 1/2 × Withdrawn × 30 days × Clear all

NCT07585734 2026-05-14

Clinical Trial of CD38 Monoclonal Antibody Combined With Chemotherapy for T-Cell Acute Lymphoblastic Leukemia

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma